I was thinking a large pharma would want to jv--invest in the further clinical development--with the idea of a long term product/marketing venture if the results after several US patients and global patients showed positive results (probably in the fall). kind of like the Korean deal only with more favorable terms. Thank you in advance.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.